{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,3]],"date-time":"2026-05-03T23:29:34Z","timestamp":1777850974567,"version":"3.51.4"},"reference-count":20,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,3,7]],"date-time":"2027-03-07T00:00:00Z","timestamp":1804377600000},"content-version":"am","delay-in-days":279,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ijcard.2026.134265","type":"journal-article","created":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T00:29:12Z","timestamp":1772497752000},"page":"134265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Racial differences in natriuretic peptide levels in wild type transthyretin amyloid cardiomyopathy"],"prefix":"10.1016","volume":"452","author":[{"given":"Brian C.","family":"Boursiquot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Muhammad Ali","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergio","family":"Teruya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mazen","family":"Hanna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathew S.","family":"Maurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2026.134265_bb0005","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jacc.2016.06.033","article-title":"Natural history of wild-type transthyretin cardiac amyloidosis and risk stratification using a novel staging system","volume":"68","author":"Grogan","year":"2016","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2026.134265_bb0010","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1093\/eurheartj\/ehx589","article-title":"A new staging system for cardiac transthyretin amyloidosis","volume":"39","author":"Gillmore","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2026.134265_bb0015","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2026.134265_bb0020","article-title":"Vutrisiran in patients with transthyretin amyloidosis with cardiomyopathy","author":"Fontana","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2026.134265_bb0025","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1056\/NEJMoa2305434","article-title":"Efficacy and safety of acoramidis in transthyretin amyloid cardiomyopathy","volume":"390","author":"Gillmore","year":"2024","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2026.134265_bb0030","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.001831","article-title":"Racial differences in circulating natriuretic peptide levels: the atherosclerosis risk in communities study","volume":"4","author":"Gupta","year":"2015","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcard.2026.134265_bb0035","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.amjcard.2017.06.030","article-title":"Differences in natriuretic peptide levels by race\/ethnicity (from the multi-ethnic study of atherosclerosis)","volume":"120","author":"Gupta","year":"2017","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2026.134265_bb0040","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1001\/jamacardio.2017.4207","article-title":"Racial differences in plasma levels of N-terminal pro-B-type natriuretic peptide and outcomes: the reasons for geographic and racial differences in stroke (REGARDS) study","volume":"3","author":"Bajaj","year":"2018","journal-title":"JAMA Cardiol."},{"key":"10.1016\/j.ijcard.2026.134265_bb0045","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jchf.2023.07.018","article-title":"Natriuretic peptide normative levels and deficiency: the National Health and Nutrition Examination Survey","volume":"12","author":"Shetty","year":"2024","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.ijcard.2026.134265_bb0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajpc.2023.100526","article-title":"Racial and ethnic differences in circulating N-terminal pro-brain-type natriuretic peptide (NT-proBNP) in US adults","volume":"15","author":"Commodore-Mensah","year":"2023","journal-title":"Am. J. Prev. Cardiol."},{"key":"10.1016\/j.ijcard.2026.134265_bb0055","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1161\/CIRCULATIONAHA.120.046374","article-title":"Racial differences in serial NT-proBNP levels in heart failure management: insights from the GUIDE-IT trial","volume":"142","author":"Parcha","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2026.134265_bb0060","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007829","article-title":"Racial and ethnic differences in biomarkers, health status, and cardiac remodeling in patients with heart failure with reduced ejection fraction treated with sacubitril\/valsartan","volume":"13","author":"Ibrahim","year":"2020","journal-title":"Circ. Heart Fail."},{"key":"10.1016\/j.ijcard.2026.134265_bb0065","first-page":"1202","article-title":"Ethnicity in systemic AL amyloidosis may impact risk stratification","volume":"110","author":"Khwaja","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/j.ijcard.2026.134265_bb0070","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.jchf.2019.12.010","article-title":"Natriuretic peptides as inclusion criteria in clinical trials: a JACC: heart failure position paper","volume":"8","author":"Ibrahim","year":"2020","journal-title":"JACC Heart Fail."},{"key":"10.1016\/j.ijcard.2026.134265_bb0075","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1161\/01.CIR.0000081657.83724.A7","article-title":"Heritability and genetic linkage of plasma natriuretic peptide levels","volume":"108","author":"Wang","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2026.134265_bb0080","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229280","article-title":"Racial\/ethnic differences in circulating natriuretic peptide levels: the diabetes prevention program","volume":"15","author":"Gupta","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ijcard.2026.134265_bb0085","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1161\/CIRCULATIONAHA.105.568881","article-title":"Corin gene minor allele defined by 2 missense mutations is common in blacks and associated with high blood pressure and hypertension","volume":"112","author":"Dries","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2026.134265_bb0090","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1161\/CIRCRESAHA.119.315026","article-title":"Race, natriuretic peptides, and high-carbohydrate challenge: a clinical trial","volume":"125","author":"Patel","year":"2019","journal-title":"Circ. Res."},{"key":"10.1016\/j.ijcard.2026.134265_bb0095","first-page":"1487","article-title":"Disparities in diagnosis and outcomes in American patients with transthyretin cardiac amyloidosis","volume":"41","author":"Ngouchet Nouhossi","year":"2025","journal-title":"Int. J. Card. Imaging"},{"key":"10.1016\/j.ijcard.2026.134265_bb0100","article-title":"Clinical implications of the P.V142I TTR variant: insights from CARS","author":"Wees","year":"2025","journal-title":"JACC Heart Fail."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527326001130?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527326001130?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T22:14:32Z","timestamp":1777500872000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527326001130"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":20,"alternative-id":["S0167527326001130"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2026.134265","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Racial differences in natriuretic peptide levels in wild type transthyretin amyloid cardiomyopathy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2026.134265","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"134265"}}